{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:51:52Z","timestamp":1792590712378,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Transarterial chemoembolization (TACE) is an effective locoregional therapy in hepatocellular carcinoma (HCC). However, it is difficult to predict the tumour response (TR) of TACE intraprocedurally. The aim of this study was to predict the TR after TACE (1\u20133\u2009months) in HCC patients using intraprocedural intraarterial contrast enhanced ultrasound (IA-CEUS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this case-control study, consecutive patients who received TACE in our hospital from September 2018 to May 2019 were enrolled. IA-CEUS was performed before and after TACE. Postoperative contrast-enhanced liver MRI was performed 1\u20133\u2009months after TACE as the gold standard. According to the modified Response Evaluation Criteria in Solid Tumours (mRECIST), ultrasonic manifestations were compared between the complete remission (CR) group and non-CR group by univariate and multivariate analyses. A logistic predictive model was established and validated, and its diagnostic efficiency was evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty-four patients with sixty-one lesions were enrolled in the study. Multivariate analysis identified, the risk factors as a large lesion diameter (OR: 1.84; 95% confidence interval [CI]: 1.009, 3.080; <jats:italic>P<\/jats:italic>\u2009=\u20090.020), a larger dimension of non-enhancing area in superior mesenteric artery (SMA)-CEUS than the size in B-mode ultrasound preoperatively (OR: 3.379; 95% CI: 1.346,8.484; <jats:italic>P<\/jats:italic>\u2009=\u20090.010), presence of corona enhancement in hepatic artery (HA)-CEUS postoperatively (OR: 6.642; 95% CI: 1.214, 36.331; <jats:italic>P<\/jats:italic>\u2009=\u20090.029), and decreased corona enhancement thickness (per centimetre) postoperatively (OR: 0.025; 95% CI: 0.006,0.718; <jats:italic>P<\/jats:italic>\u2009=\u20090.025). The area under the receiver operating characteristic curve (AUROC) of the predictive model was 0.904 (95% CI: 0.804, 0.966; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were 81.08, 91.67, 85.25, 93.75, and 75.86%, respectively. Leave-one-out cross-validation (LOOCV) showed that the accuracy was 77.05%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Intraprocedural IA-CEUS can be used to predict the TR in HCC patients after TACE.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08867-5","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T16:39:22Z","timestamp":1635871162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol"],"prefix":"10.1186","volume":"21","author":[{"given":"Jiang","family":"Bo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"LianHua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"YuKun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"issue":"3","key":"8867_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"8867_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L: EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236.","journal-title":"J Hepatol"},{"issue":"1","key":"8867_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/hep.28453","volume":"64","author":"R Lencioni","year":"2016","unstructured":"Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF. Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. Hepatology (Baltimore, Md). 2016;64(1):106\u201316.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"8867_CR4","first-page":"136","volume":"20","author":"H Moschouris","year":"2014","unstructured":"Moschouris H, Malagari K, Papadaki MG, Kornezos I, Stamatiou K, Anagnostopoulos A, et al. mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization. Diagn Interv Radiol (Ankara, Turkey). 2014;20(2):136\u201342.","journal-title":"Diagn Interv Radiol (Ankara, Turkey)"},{"issue":"1","key":"8867_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52\u201360. https:\/\/doi.org\/10.1055\/s-0030-1247132.","journal-title":"Semin Liver Dis"},{"issue":"3","key":"8867_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/RCT.0000000000000070","volume":"38","author":"DM Yeo","year":"2014","unstructured":"Yeo DM, Choi JI, Lee YJ, Park MY, Chun HJ, Lee HG. Comparison of RECIST, mRECIST, and choi criteria for early response evaluation of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads. J Comput Assist Tomogr. 2014;38(3):391\u20137. https:\/\/doi.org\/10.1097\/RCT.0000000000000070.","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"8867_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.21037\/jgo.2019.01.01","volume":"10","author":"R Yamada","year":"2019","unstructured":"Yamada R, Bassaco B, Bracewell S, Gillen K, Kocher M, Collins H, et al. Long-term follow-up after conventional transarterial chemoembolization (c-TACE) with mitomycin for hepatocellular carcinoma (HCC). J Gastrointest Oncol. 2019;10(2):348\u201353. https:\/\/doi.org\/10.21037\/jgo.2019.01.01.","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"8867_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1148\/radiol.14131311","volume":"272","author":"D Wang","year":"2014","unstructured":"Wang D, Gaba RC, Jin B, Lewandowski RJ, Riaz A, Memon K, et al. Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology. 2014;272(2):587\u201397. https:\/\/doi.org\/10.1148\/radiol.14131311.","journal-title":"Radiology"},{"issue":"1","key":"8867_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7150\/thno.16899","volume":"7","author":"F Lin","year":"2017","unstructured":"Lin F, Shelton SE, Esp\u00edndola D, Rojas JD, Pinton G, Dayton PA. 3-D ultrasound localization microscopy for identifying microvascular morphology features of tumor angiogenesis at a resolution beyond the diffraction limit of conventional ultrasound. Theranostics. 2017;7(1):196\u2013204. https:\/\/doi.org\/10.7150\/thno.16899.","journal-title":"Theranostics"},{"issue":"5","key":"8867_CR10","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1109\/TBME.2015.2479590","volume":"63","author":"SR Rao","year":"2016","unstructured":"Rao SR, Shelton SE, Dayton PA. The \"fingerprint\" of Cancer extends beyond solid tumor boundaries: assessment with a novel ultrasound imaging approach. IEEE Trans Biomed Eng. 2016;63(5):1082\u20136. https:\/\/doi.org\/10.1109\/TBME.2015.2479590.","journal-title":"IEEE Trans Biomed Eng"},{"issue":"2","key":"8867_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1148\/rg.2020190183","volume":"40","author":"CD Malone","year":"2020","unstructured":"Malone CD, Fetzer DT, Monsky WL, Itani M, Mellnick VM, Velez PA, et al. Contrast-enhanced US for the interventional radiologist: current and emerging applications. Radiographics. 2020;40(2):562\u201388. https:\/\/doi.org\/10.1148\/rg.2020190183.","journal-title":"Radiographics"},{"issue":"2","key":"8867_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.carj.2015.09.006","volume":"67","author":"RY Chiu","year":"2016","unstructured":"Chiu RY, Yap WW, Patel R, Liu D, Klass D, Harris AC. Hepatocellular Carcinoma Post Embolotherapy: Imaging Appearances and Pitfalls on Computed Tomography and Magnetic Resonance Imaging. Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes. 2016;67(2):158\u201372.","journal-title":"Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes"},{"issue":"20","key":"8867_CR13","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.3748\/wjg.v22.i20.4835","volume":"22","author":"K Yang","year":"2016","unstructured":"Yang K, Zhang XM, Yang L, Xu H, Peng J. Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2016;22(20):4835\u201347. https:\/\/doi.org\/10.3748\/wjg.v22.i20.4835.","journal-title":"World J Gastroenterol"},{"key":"8867_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mri.2019.06.017","volume":"62","author":"A Thibodeau-Antonacci","year":"2019","unstructured":"Thibodeau-Antonacci A, Petitclerc L, Gilbert G, Bilodeau L, Olivi\u00e9 D, Cerny M, et al. Dynamic contrast-enhanced MRI to assess hepatocellular carcinoma response to Transarterial chemoembolization using LI-RADS criteria: a pilot study. Magn Reson Imaging. 2019;62:78\u201386. https:\/\/doi.org\/10.1016\/j.mri.2019.06.017.","journal-title":"Magn Reson Imaging"},{"issue":"25","key":"8867_CR15","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.3748\/wjg.v16.i25.3161","volume":"16","author":"JC Chung","year":"2010","unstructured":"Chung JC, Naik NK, Lewandowski RJ, Deng J, Mulcahy MF, Kulik LM, et al. Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World J Gastroenterol. 2010;16(25):3161\u20137. https:\/\/doi.org\/10.3748\/wjg.v16.i25.3161.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"8867_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.8725","volume":"4","author":"W Ma","year":"2014","unstructured":"Ma W, Jia J, Wang S, Bai W, Yi J, Bai M, et al. The prognostic value of 18F-FDG PET\/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE). Theranostics. 2014;4(7):736\u201344. https:\/\/doi.org\/10.7150\/thno.8725.","journal-title":"Theranostics"},{"issue":"3","key":"8867_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.diii.2016.09.002","volume":"98","author":"SB Paul","year":"2017","unstructured":"Paul SB, Dhamija E, Gamanagatti SR, Sreenivas V, Yadav DP, Jain S, et al. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: comparison of contrast-enhanced ultrasound with multiphase computed tomography. Diagn Interv Imaging. 2017;98(3):253\u201360. https:\/\/doi.org\/10.1016\/j.diii.2016.09.002.","journal-title":"Diagn Interv Imaging"},{"issue":"2","key":"8867_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3350\/cmh.2015.21.2.165","volume":"21","author":"YZ Cho","year":"2015","unstructured":"Cho YZ, Park SY, Choi EH, Baik SK, Kwon SO, Kim YJ, et al. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study. Clin Mol Hepatol. 2015;21(2):165\u201374. https:\/\/doi.org\/10.3350\/cmh.2015.21.2.165.","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"8867_CR19","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1007\/s00330-015-3611-9","volume":"25","author":"M Liu","year":"2015","unstructured":"Liu M, Lin MX, Lu MD, Xu ZF, Zheng KG, Wang W, et al. Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST. Eur Radiol. 2015;25(8):2502\u201311. https:\/\/doi.org\/10.1007\/s00330-015-3611-9.","journal-title":"Eur Radiol"},{"issue":"10","key":"8867_CR20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1872-034X.2012.01019.x","volume":"42","author":"R Kita","year":"2012","unstructured":"Kita R, Sakamoto A, Nagata Y, Nishijima N, Ikeda A, Matsuo H, et al. Visualization of blood drainage area from hypervascular hepatocellular carcinoma on ultrasonographic images during hepatic arteriogram: comparison with depiction of drainage area on contrast-enhanced ultrasound. Hepatol Res. 2012;42(10):999\u20131007. https:\/\/doi.org\/10.1111\/j.1872-034X.2012.01019.x.","journal-title":"Hepatol Res"},{"issue":"1\u20134","key":"8867_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3233\/CH-2011-1457","volume":"49","author":"W Uller","year":"2011","unstructured":"Uller W, Wiggermann P, G\u00f6ssmann H, Klebl F, Salzberger B, Stroszczynski C, et al. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data. Clin Hemorheol Microcirc. 2011;49(1\u20134):55\u201366. https:\/\/doi.org\/10.3233\/CH-2011-1457.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"5","key":"8867_CR22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00261-016-1016-0","volume":"42","author":"I Lekht","year":"2017","unstructured":"Lekht I, Nayyar M, Luu B, Guichet PL, Ho J, Ter-Oganesyan R, et al. Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series. Abdominal radiology (New York). 2017;42(5):1400\u20137. https:\/\/doi.org\/10.1007\/s00261-016-1016-0.","journal-title":"Abdominal radiology (New York)"},{"issue":"2\u20133","key":"8867_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/CH-2010-1338","volume":"46","author":"N Zorger","year":"2010","unstructured":"Zorger N, Jung EM, Schreyer AG, Heiss P, Mueller-Wille R, Wiest R, et al. Ultrasound-arterioportography (US-AP): a new technical approach to perform detection of liver lesions. Clin Hemorheol Microcirc. 2010;46(2\u20133):117\u201326. https:\/\/doi.org\/10.3233\/CH-2010-1338.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"2","key":"8867_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1148\/radiol.2522081414","volume":"252","author":"A Kitao","year":"2009","unstructured":"Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. Radiology. 2009;252(2):605\u201314. https:\/\/doi.org\/10.1148\/radiol.2522081414.","journal-title":"Radiology"},{"issue":"4","key":"8867_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3892\/or.15.4.785","volume":"15","author":"K Yamamoto","year":"2006","unstructured":"Yamamoto K, Nakanishi S, Fuke H, Hashimoto A, Shimizu A, Hamataki T, et al. Corona enhancement in ultrasonographical post-vascular phase images with microbubble contrast agent: a novel specific sign for hepatocellular carcinomas. Oncol Rep. 2006;15(4):785\u201390. https:\/\/doi.org\/10.3892\/or.15.4.785.","journal-title":"Oncol Rep"},{"issue":"3","key":"8867_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1148\/radiol.2019190305","volume":"293","author":"R Duran","year":"2019","unstructured":"Duran R, Namur J, Pascale F, Czuczman P, Bascal Z, Kilpatrick H, et al. Vandetanib-eluting radiopaque beads: pharmacokinetics, safety, and efficacy in a rabbit model of liver Cancer. Radiology. 2019;293(3):695\u2013703. https:\/\/doi.org\/10.1148\/radiol.2019190305.","journal-title":"Radiology"},{"issue":"2","key":"8867_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jvir.2016.09.019","volume":"28","author":"K M\u00fcller","year":"2017","unstructured":"M\u00fcller K, Datta S, Gehrisch S, Ahmad M, Mohammed MA, Rosenberg J, et al. The role of dual-phase cone-beam CT in predicting short-term response after Transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2017;28(2):238\u201345. https:\/\/doi.org\/10.1016\/j.jvir.2016.09.019.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"8867_CR28","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.21037\/tcr.2020.04.17","volume":"9","author":"X Fei","year":"2020","unstructured":"Fei X, Wang Z-J, Li Y, Han P, Li X-H, Jiang B. The value of intra-procedural transcatheter intraarterial contrast-enhanced ultrasonography (IA-CEUS) in predicting the short-term efficacy of conventional transarterial chemoembolization (cTACE). Transl Cancer Res. 2020;9(5):3600\u20139. https:\/\/doi.org\/10.21037\/tcr.2020.04.17.","journal-title":"Transl Cancer Res"},{"issue":"2","key":"8867_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/RCT.0b013e318245c23c","volume":"36","author":"L Yang","year":"2012","unstructured":"Yang L, Zhang XM, Tan BX, Liu M, Dong GL, Zhai ZH. Computed tomographic perfusion imaging for the therapeutic response of chemoembolization for hepatocellular carcinoma. J Comput Assist Tomogr. 2012;36(2):226\u201330. https:\/\/doi.org\/10.1097\/RCT.0b013e318245c23c.","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"8867_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/jum.15118","volume":"39","author":"Y Watanabe","year":"2020","unstructured":"Watanabe Y, Ogawa M, Kumagawa M, Hirayama M, Miura T, Matsumoto N, et al. Utility of contrast-enhanced ultrasound for early therapeutic evaluation of hepatocellular carcinoma after Transcatheter arterial chemoembolization. J Ultrasound Med. 2020;39(3):431\u201340. https:\/\/doi.org\/10.1002\/jum.15118.","journal-title":"J Ultrasound Med"},{"issue":"1","key":"8867_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/hep.31022","volume":"72","author":"G Han","year":"2020","unstructured":"Han G, Berhane S, Toyoda H, Bettinger D, Elshaarawy O, Chan AWH, et al. Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach. Hepatology (Baltimore, Md). 2020;72(1):198\u2013212.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"8867_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.15403\/jgld.2014.1121.274.fcr","volume":"27","author":"R Cerban","year":"2018","unstructured":"Cerban R, Ester C, Iacob S, Grasu M, P\u00e2slaru L, Dumitru R, et al. Predictive factors of tumor recurrence and survival in patients with hepatocellular carcinoma treated with Transarterial chemoembolization. J Gastrointest Liver Dis. 2018;27(4):409\u201317. https:\/\/doi.org\/10.15403\/jgld.2014.1121.274.fcr.","journal-title":"J Gastrointest Liver Dis"},{"issue":"10","key":"8867_CR33","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1007\/s00330-021-07910-0","volume":"31","author":"C Kong","year":"2021","unstructured":"Kong C, Zhao Z, Chen W, Lv X, Shu G, Ye M, et al. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE. Eur Radiol. 2021;31(10):7500\u201311. https:\/\/doi.org\/10.1007\/s00330-021-07910-0.","journal-title":"Eur Radiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08867-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08867-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08867-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T16:40:57Z","timestamp":1635871257000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08867-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8867"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08867-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"12 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This single-centre study was approved by the Ethics Committee of the Chinese People\u2019s Liberation Army General Hospital (Approval No. S2020\u2013427-01). All the patients provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no competing interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1171"}}